I am sure I read somewhere that you don't need a separate clinical trial done in the US for OSA due to there being currently no gold standard for diagnosis so it will likely be submission for all 3 markets (likely why BL said it will be bigger than ResAppDx for right now....).
- Forums
- ASX - By Stock
- RAP
- TechKnow Sydney
TechKnow Sydney, page-20
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 279 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)